Strengths

● The stock, which is currently worth 2019 to 0.66 times its sales, is clearly overvalued in comparison with peers.

● The stock is in a well-established, long-term rising trend above the technical support level at 3.83 EUR


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 4.32.

● The stock is close to a major daily resistance at EUR 4.32, which should be gotten rid of so as to gain new appreciation potential.

● The company does not generate enough profits, which is an alarming weak point.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.29 times its estimated earnings per share for the ongoing year.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.